JANECE MOORE: Open Payments
NPI 1811235294 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,713 in 78 payments from 16 companies in 2025. Trend: 2023 $1,887 · 2024 $1,563 · 2025 $1,713
Food & beverage: $1,683Long term medical supply or device loan: $30
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 25 | $463 |
| AstraZeneca Pharmaceuticals LP | 11 | $208 |
| Abbott Laboratories | 11 | $180 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $164 |
| PFIZER INC. | 2 | $145 |
| Corcept Therapeutics | 4 | $126 |
| Lilly USA, LLC | 5 | $99 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $84 |
| ABBVIE INC. | 3 | $74 |
| Esperion Therapeutics, Inc. | 2 | $37 |
Products named: Wegovy, Kerendia, FREESTYLE LIBRE 3, FARXIGA, Korlym, ZAVZPRET, JARDIANCE, AIRSUPRA.
Industry payments across NC — which companies pay providers there.
